News


Heritage Cannabis Achieves Major Milestone with Products Now Available through Spectrum Therapeutics

January 28th, 2022 - Ryan Allway

Further Expands Heritage’s Product Distribution in the Medical Channel with one of Canada’s Largest Online Medical Cannabis Platforms   TORONTO, January 28, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company“), is pleased to announce that Spectrum Therapeutics (“Spectrum“), one of Canada’s largest online medical cannabis platforms, is now offering Heritage products including […]

The Parent Company Announces Voluntary Extension of Boar of Director and Leadership Team Lock-Up Agreements

January 28th, 2022 - Ryan Allway

~35% of the Company’s Common Shares to Be Voluntarily Locked-Up for An Additional Twelve Months SAN JOSE, Calif, Jan. 28, 2022 /CNW/ – TPCO Holding Corp. (“The Parent Company” or the “Company”) (NEO: GRAM.U) (OTCQX: GRAMF), a leading vertically-integrated California cannabis company, announced today that certain insiders (the “Insiders”) have individually voluntarily entered into a twelve-month extension of lock-up […]

Oklahoma City Dispensary Becomes a Unity Rd. Local Alliance Partner

January 27th, 2022 - Ryan Allway

National Cannabis Dispensary Franchise Progresses Midwest Growth; Local Alliance Program Aims to Keep Dispensary Ownership Local by Providing Existing Owners the Backing of a National Franchise System   OKLAHOMA CITY, Jan. 27, 2022 /PRNewswire/ — Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), announced today it has signed its first partner through its Local Alliance […]

Cognetivity Neurosciences Appoints Emitac Healthcare Solutions as Authorized Distributor in Middle East Region

January 27th, 2022 - Ryan Allway

Announcement of distribution agreement coincides with appearance of both companies at Arab Health 2022, the largest medical equipment exhibition in the Middle East   VANCOUVER, BC, Jan. 27, 2022 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB) today announced that it has signed a distribution agreement with Dubai-based medical technology company Emitac […]

SciSparc Presents New Leadership Lineup

January 27th, 2022 - Ryan Allway

TEL AVIV, Israel, Jan. 27, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), announced that its board of directors (the “Board”) resolved to appoint Mr. Oz Adler as the Chief Executive Officer, Mr. Itschak Shrem as the President of […]

THC BioMed Granted License to Cultivate Cannabis for Medical and Scientific Use

January 27th, 2022 - Ryan Allway

VANCOUVER, BC, Jan. 27, 2022 /CNW/ – THC BioMed Intl Ltd. (“THC BioMed” or the “Company“) announces that it has been granted a licence by an overseas government to cultivate cannabis for medical and scientific use.   We are in advanced discussions with the host government to conduct Scientific Research with Cannabis. We intend to conduct scientific […]

/R E P E A T – Nova Mentis and KGK Science Form Tactical Partnership/

January 27th, 2022 - Ryan Allway

The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada   VANCOUVER, BC, Jan. 27, 2022 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce that the Company has […]

RYAH Closes Initial Tranche of Private Placement Units

January 27th, 2022 - Ryan Allway

TORONTO, ON / ACCESSWIRE / January 27, 2022 / RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company“) is pleased to provide an update to its previously announced non-brokered private placement of units of the Company (“Units“) for aggregate gross proceeds of up to C$1,500,000, at an issue price of C$0.05 per Unit (the “Private Placement“). As […]

RYAH and Bazelet Enter Into MOU for 5-Year Medical Device Distribution Strategy for the RYAH Smart Inhaler in Israel

January 27th, 2022 - Ryan Allway

The proposed collaboration is being undertaken to secure Israel Ministry of Health Medical Device certification for the RYAH Smart Inhaler via Bazelet’s Quality Team. The parties are expected to negotiate a multi-year exclusive commercial distribution arrangement in the region, following a successful medical device certification. TORONTO, ON / ACCESSWIRE / January 27, 2022 / RYAH Group, […]

Flora Growth Appoints Award-Winning Operations Expert Joël Reyes as SVP of Global Operations

January 27th, 2022 - Ryan Allway

Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of operations and personnel development expert, Joël Reyes as Senior Vice President of Global Operations. Mr. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and […]

NutraLife Biosciences, inc. to Webcast Live at VirtualInvestorConferences.com February 3rd

January 27th, 2022 - Ryan Allway

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com COCONUT CREEK, Fla., Jan. 27, 2022 (GLOBE NEWSWIRE) — NutraLife Biosciences, inc. (OTC:NLBS) today announced that Edgar Ward, CEO, will present live at VirtualInvestorConferences.com on February 3rd , 2022. DATE: February 3 rd , 2022 TIME: 10:30 am LINK: https://bit.ly/3JUNHjN This will be a […]

Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences

January 26th, 2022 - Ryan Allway

VANCOUVER, British Columbia, Jan. 26, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has signed a consulting agreement with the Universitat de Barcelona (the “University of Barcelona” or the “University”), Faculty of Pharmacy and […]

Audacious Firing on all Cylinders

January 26th, 2022 - Ryan Allway

LAS VEGAS, Jan. 26, 2022 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA“, “AUDACIOUS” or the “Company“) is pleased to provide the following corporate update:   Australis Capital Inc. logo (CNW Group/Australis Capital Inc.) “We are executing both within the U.S. and internationally, rapidly expanding our footprint, brand recognition and product offerings, while developing new […]

Clever Leaves Enters US Consumer CBD Market

January 26th, 2022 - Ryan Allway

BOCA RATON, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced its entrance to the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol™. JoySol is produced by Arizona-based Herbal Brands, […]

Halo Collective Completes Acquisition of H2C Beverages and Securities Issuance to Independent Consultants and Related Parties

January 26th, 2022 - Ryan Allway

TORONTO, Jan. 25, 2022 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) has completed the previously announced acquisition of 1285826 B.C. Ltd. (dba H2C Beverages) (“H2C”), a company focused on cannabinoids and non-psychotropic mushroom functional beverages. The Company also announced the issuance of 1,981,349 common shares of the Company (the “Compensation Shares”) to certain independent […]

High Tide Announces Opening of Two New Canna Cabana Locations in Regina

January 26th, 2022 - Ryan Allway

CALGARY, January 26, 2022 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that its Canna Cabana retail cannabis store located at 3710 Eastgate Drive in Regina, Saskatchewan (the “Eastgate Drive store”) has […]

BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M

January 26th, 2022 - Ryan Allway

2022 Revenue will include sales of VINIA® and Cannabis, both with high gross margins Major investments in the BioFarming platform and Intellectual property New patent application covers a 700% increase in Bioreactor production output Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – January 26, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) announces that following […]

One World Products Announces the Addition of Jim Hackney to Advisory Board as Chief Global Strategist

January 25th, 2022 - Ryan Allway

In His Role, Mr. Hackney Will Focus on International Initiatives and Affairs as One World Seeks to Expand its Global Platform of Sustainable Hemp and Cannabis Solutions   Mr. Hackney Joins Recently Appointed Board Chair Minyon Moore in Strengthening Company’s Advisory Board; Both Will Drive One World’s Global Expansion Efforts into New Markets and Sectors   […]

Icanic Brands Announces Definitive Agreement to Acquire 100% of LEEF Holdings, California’s Premier Extraction Company

January 25th, 2022 - Ryan Allway

VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator of premium Cannabis brands in California and Nevada, is pleased to announce that the Company has entered into a definitive agreement (the “Agreement”) with LEEF Holdings, Inc. (“LEEF”), a […]

Labstat International Inc. & The Blinc Group Study Finds Vape Habits Don’t Cross Borders

January 25th, 2022 - Ryan Allway

Labstat International Inc., Canada’s leading independent third-party cannabis testing company, in partnership with The Blinc Group, Inc., the regulatory-focused designer and provider of premium, customized and bespoke vaporizer technologies, have conducted the first North American Cannabis Vape Consumption Survey aimed at better understanding how consumers use vaping devices. The study, Cannabis Puffing Regimes: A first step in […]

West Island Closes on 1st Tranche of Private Placement

January 25th, 2022 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – January 25, 2022) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) (“West Island” or the “Company”) is pleased to announce that it has the first tranche a non-brokered private placement consisting of 1,080,000 units at a price of $0.25 per unit for aggregate gross proceeds of $270,000.00. Each unit is […]

Akerna Releases 2021 Cannabis Industry Year-End Review

January 25th, 2022 - Ryan Allway

2021 brought the largest cannabis sales day ever, the first-ever comprehensive cannabis reform bills, new markets, new opportunities, and so much more   DENVER, Jan. 25, 2022 /PRNewswire/ — Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of the most comprehensive technology infrastructure, ecosystem, and compliance engine powering the global cannabis industry, today announced the release […]

Craftport Cannabis Announces $3 Million Private Placement

January 25th, 2022 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – January 25, 2022) – Craftport Cannabis Corp. (CSE: CFT) (“Craftport Cannabis” or the “Company”) is pleased to announce a non-brokered private placement offering (the “Offering”) of up to 15,000,000 common shares at a price of $0.20 per common share for gross proceeds of $3 million. The Company expects to close […]

Psychedelic Treatment for Depression Moving Toward Clinical Trials

January 25th, 2022 - Robin Lefferts

Depression, or more formally Major Depressive Disorder (MDD), is a widespread and growing problem across the globe. In the United States in 2019, 19.4 million adults (7.8% of all adults) were estimated to have a major depressive episode. About two-thirds of these people received treatment of some sort, and the most effective treatments produce roughly 30 to 40 […]

Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France

January 24th, 2022 - Ryan Allway

The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry   Both companies have previously issued their premium oils to patients in France   DÜSSELDORF, Germany and TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ — Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), a global pharma company which develops, manufactures and markets […]

Sugarmade Signs Binding LOI to Enter Rare Cannabinoid Market via License Agreement for Patented THC-V Rich Chemovars

January 24th, 2022 - Ryan Allway

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Sugarmade, Inc. (OTC Pink: SGMD) (“Sugarmade”, “SGMD” or the “Company”) an emerging leader in the licensed cannabis sector, is pleased to announce the signing of a binding Letter of Intent (the “LOI”) with GenCann, Inc. (“GenCann”), the exclusive licensor for a set of cannabis chemovars particularly […]

Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders

January 24th, 2022 - Ryan Allway

SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a “Pure Play” Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier Pharmaceuticals   JUPITER, FL / ACCESSWIRE / January 24, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it intends to dividend its wholly-owned subsidiary, SRM Entertainment to […]

Sunstream Opportunities LP Receives Investment Grade Credit Rating

January 24th, 2022 - Ryan Allway

CALGARY, AB, Jan. 24, 2022 /PRNewswire/ – Sunstream Opportunities LP, an affiliate of Sunstream Bancorp Inc., a joint venture sponsored by Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial”), has been assigned an investment grade rating of BBB+ by Egan-Jones Ratings Company, an independent, unaffiliated rating agency.   “The investment grade credit rating assigned from Egan-Jones is a testament to the […]

The Newly Institute Announces Appointment of Danny Williams, Former Premier of Newfoundland and Labrador, to Board of Directors

January 24th, 2022 - Ryan Allway

Mr. Williams’ strong business acumen and corporate governance experience will be valuable to The Newly Institute as it continues to expand its inter-disciplinary mental health clinics across Canada   Calgary, Alberta–(Newsfile Corp. – January 24, 2022) – The Newly Institute Inc. (“The Newly” or the “Company“), Canada’s leading inter-disciplinary mental health clinical organization that offers […]

OTC Markets Group Welcomes Mystic Holdings Inc. to OTCQX

January 21st, 2022 - Ryan Allway

NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Mystic Holdings Inc. (OTCQX: MSTH), a company focused on cannabis cultivation, production and retail, has qualified to trade on the OTCQX® Best Market. Mystic Holdings Inc. upgraded to OTCQX from the Pink® […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading